Debiopharma S.A.
29Patents
6Active
29Granted
36Portfolio score
Filing activity: Jul 19, 1979 → May 12, 2016 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5286637A | Biologically active drug polymer derivatives and method for preparing same | Emerging Cross-Sectional Technologies | 154 | Expired |
| US5192741A | Sustained and controlled release of water insoluble polypeptides | Human Necessities | 141 | Expired |
| US5225205A | Pharmaceutical composition in the form of microparticles | Human Necessities | 79 | Expired |
| US5134122A | Method for preparing a pharmaceutical composition in the form of microparticles | Human Necessities | 68 | Expired |
| US4835139A | Process for increasing the antagonistic effect of peptidic compounds on hormone-dependent diseases | Emerging Cross-Sectional Technologies | 57 | Expired |
| US5716988A | Pharmaceutically stable preparation of oxaliplatinum | Human Necessities | 47 | Expired |
| US8440679B2 | Bicyclic compounds and their uses as dual c-SRC / JAK inhibitors | Human Necessities | 46 | Active |
| US4839343A | Preparation containing hexatriacontapeptides and methods of use | Human Necessities | 41 | Expired |
| US6927208B1 | Cyclosporin with improved activity profile | Human Necessities | 37 | Expired |
| US5922358A | Antithrombotic and non-hemorrhagic heparin-based compositions, process for their preparation and therapeutic applications | Human Necessities | 27 | Expired |
| US6790935B1 | Cyclosporin derivatives and method for the production of said derivatives | Chemistry; Metallurgy | 23 | Expired |
| US6814982B2 | Suspension of an EPI-HNE protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses | Human Necessities | 20 | Expired |
| US5187150A | Polyester-based composition for the controlled release of polypeptide medicinal substances | Human Necessities | 18 | Expired |
| US5635515A | Therapeutic agents for the treatment of multiple drug resistance of cancers | Human Necessities | 9 | Expired |
| US6866857B1 | Oxalipatinum preparation packaging | Human Necessities | 8 | Expired |
| US4673595A | Microencapsulation by phase separation of water-soluble medicaments | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4312862A | Therapeutically active derivatives of benzamide | Chemistry; Metallurgy | 5 | Expired |
| US6518278B1 | Carcinostatic substance for compatible administration, process of administrating same and process of rapidly inspecting same | Human Necessities | 4 | Expired |
| US7070796B1 | Pharmaceutically stable oxaliplatinum preparation for parenteral administration | Human Necessities | 3 | Expired |
| US6995139B2 | Cyclic undecapeptide pro-drugs and uses thereof | Human Necessities | 3 | Expired |
| US6528524B2 | Pharmaceutical compositions containing cinchonine dichlorhydrate | Emerging Cross-Sectional Technologies | 3 | Expired |
| US7012072B2 | Pharmaceutical oxaliplatinum preparation for parenteral administration and method for obtaining same | Human Necessities | 2 | Expired |
| US8962637B2 | Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors | Human Necessities | 1 | Active |
| USRE40987E1 | Cyclosporin with improved activity profile | General | 1 | Expired |
| US10188696B2 | Pharmaceutical compositions | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.